- What is Qure Ventures' primary investment focus?
- Qure Ventures is a digital health-focused fund specializing in vetting, funding, and accelerating digital health startups. They focus on deep-tech solutions aimed at improving patient care, reducing healthcare costs, and empowering consumers.
- Which sectors does Qure Ventures primarily invest in?
- Qure Ventures primarily invests in Health Tech & Life Sciences, which accounts for 14 of their investment rounds and 11 portfolio companies. They also have investments in Cyber Security, Fintech & Insurtech, and Industrial Technologies.
- Can you name a recent notable exit for Qure Ventures?
- In February 2022, Qure Ventures saw an exit with the acquisition of CyberMDX by Forescout Technologies for $80M.
- What was another significant exit for Qure Ventures in the last two years?
- In August 2021, Qure Ventures had an exit with the acquisition of Zebra Medical Vision by Nanox Vision for $200M.
- What investment stages does Qure Ventures typically engage in?
- Qure Ventures invests across Pre-Seed, Seed, and A Round stages, with a notable number of follow-on investments in A and B rounds.
- Who are the managing partners at Qure Ventures?
- Qure Ventures was established and is managed by Dr. Yossi Bahagon, who serves as Managing General Partner, and Allen Kamer, who is a Managing Partner.
- What is Qure Ventures' approach to supporting its portfolio companies?
- Qure Ventures takes a hands-on approach, dedicating 70% of its time to leveraging its knowledge, experience, and network to support companies in strategy, business, growth, and funding. They also utilize global strategic partners for market access and clinical validation.
- Can you name one of Qure Ventures' active portfolio companies in the digital therapeutics space?
- DarioHealth (formerly LabStyle Innovations) is one of Qure Ventures' portfolio companies, focusing on digital therapeutics for treating chronic conditions.